A contract development and manufacturing organization focused on small‑molecule active pharmaceutical ingredients and intermediates used in branded and generic drugs. The company provides process development, scale‑up, and commercial manufacturing services to pharmaceutical and biotechnology firms, ...
2 members of Congress have disclosed 3 trades in Cambrex Corporation (CBM), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-10-22 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-10-18 | Josh Gottheimer | sell | $1K – $15K |
| 2017-08-08 | Josh Gottheimer | buy | $1K – $15K |